Archives of Microbiology

, Volume 186, Issue 3, pp 171–181 | Cite as

Characterization of the Vibrio cholerae vexAB and vexCD efflux systems

  • James E. BinaEmail author
  • Daniele Provenzano
  • Chunmei Wang
  • Xiaowen R. Bina
  • John J. Mekalanos
Original Paper


Vibrio cholerae is an important human pathogen that causes the diarrheal disease cholera. Colonization of the human host is dependent upon coordinated expression of several virulence factors in response to as yet unknown environmental cues. Bile acids have been implicated in the in vitro regulation of several V. cholerae genes, including those involved in motility, chemotaxis, outer membrane protein production, and virulence factor production. Bile is toxic to bacteria and colonization of the intestinal tract is dependent upon bacterial resistance to bile acids. We have identified and characterized two bile-regulated RND-family efflux systems, named here vexAB and vexCD, that are involved in V. cholerae bile resistance. Mutational analysis revealed that the vexAB system is responsible for in vitro intrinsic resistance of V. cholerae to multiple antimicrobial compounds, including bile acids. In contrast, the vexCD efflux system was specific for certain bile acids and detergents and functioned in conjunction with the vexAB system to provide V. cholerae with high-level bile resistance. Mutants containing deletion of vexB, vexD, and vexB–vexD were able to efficiently colonize the infant mouse suggesting that these efflux systems were dispensable for V. cholerae growth in the small intestines of infant mice.


Cholera Efflux Bile RND 



We thank Angel Olguin for assistance with the CT and TCP assays. This study was supported by a fellowship from the Cystic Fibrosis Foundation (J.E.B.), a grant from University of Tennessee Pathogenesis Center (J.E.B), and NIH grants AI-18045 (J.J.M) and GM068855 (D.P).


  1. Allweiss B, Dostal J, Carey KE, Edwards TF, Freter R (1977) The role of chemotaxis in the ecology of bacterial pathogens of mucosal surfaces. Nature 266:448–450PubMedCrossRefGoogle Scholar
  2. Alvarez G, Heredia N, Garcia S (2003) Relationship between the effects of stress induced by human bile juice and acid treatment in Vibrio cholerae. J Food Prot 66:2283–2288PubMedGoogle Scholar
  3. Bina JE, Mekalanos JJ (2001) Vibrio cholerae tolC is required for bile resistance and colonization. Infect Immun 69:4681–4685PubMedCrossRefGoogle Scholar
  4. Bina J, Zhu J, Dziejman M, Faruque S, Calderwood S, Mekalanos J (2003) ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients. Proc Natl Acad Sci USA 100:2801–2806PubMedCrossRefGoogle Scholar
  5. Butler SM, Camilli A (2004) Both chemotaxis and net motility greatly influence the infectivity of Vibrio cholerae. Proc Natl Acad Sci USA 101:5018–5023PubMedCrossRefGoogle Scholar
  6. Chatterjee A, Chaudhuri S, Saha G, Gupta S, Chowdhury R (2004) Effect of bile on the cell surface permeability barrier and efflux system of Vibrio cholerae. J Bacteriol 186:6809–6814PubMedCrossRefGoogle Scholar
  7. Cohen SP, Hachler H, Levy SB (1993) Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol 175:1484–1492PubMedGoogle Scholar
  8. Colmer JA, Fralick JA, Hamood AN (1998) Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae. Mol Microbiol 27:63–72PubMedCrossRefGoogle Scholar
  9. Delihas N, Forst S (2001) MicF: an antisense RNA gene involved in response of Escherichia coli to global stress factors. J Mol Biol 313:1–12PubMedCrossRefGoogle Scholar
  10. Eswaran J, Koronakis E, Higgins MK, Hughes C, Koronakis V (2004) Three’s company: component structures bring a closer view of tripartite drug efflux pumps. Curr Opin Struct Biol 14:741–747PubMedCrossRefGoogle Scholar
  11. Fernandes PB, Smith HL Jr (1977) The effect of anaerobiosis and bile salts on the growth and toxin production by Vibrio cholerae. J Gen Microbiol 98:77–86PubMedGoogle Scholar
  12. Fernandez-Recio J et al (2004) A model of a transmembrane drug-efflux pump from Gram-negative bacteria. FEBS Lett 578:5–9PubMedCrossRefGoogle Scholar
  13. Gupta S, Chowdhury R (1997) Bile affects production of virulence factors and motility of Vibrio cholerae. Infect Immun 65:1131–1134PubMedGoogle Scholar
  14. Guzman LM, Belin D, Carson MJ, Beckwith J (1995) Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177:4121–4130PubMedGoogle Scholar
  15. Hancock RE (1997) The bacterial outer membrane as a drug barrier. Trends Microbiol 5:37–42PubMedCrossRefGoogle Scholar
  16. Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, Levine MM (1988) Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 168:1487–1492PubMedCrossRefGoogle Scholar
  17. Holt PR (1972) The roles of bile acids during the process of normal fat and cholesterol absorption. Arch Intern Med 130:574–583PubMedCrossRefGoogle Scholar
  18. Hung DT, Mekalanos JJ (2005) Bile acids induce cholera toxin expression in Vibrio cholerae in a ToxT-independent manner. Proc Natl Acad Sci USA 102(8):3028–3033PubMedCrossRefGoogle Scholar
  19. Hung DT, Zhu J, Sturtevant D, Mekalanos JJ (2006) Bile acids stimulate biofilm formation in Vibrio cholerae. Mol Microbiol 59:193–201PubMedCrossRefGoogle Scholar
  20. Imai Y, Matsushima Y, Sugimura T, Terada M (1991) A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res 19:2785PubMedCrossRefGoogle Scholar
  21. Iwanaga M, Yamamoto K (1985) New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor. J Clin Microbiol 22:405–408PubMedGoogle Scholar
  22. Iwanaga M, Yamamoto K, Higa N, Ichinose Y, Nakasone N, Tanabe M (1986) Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol Immunol 30:1075–1083PubMedGoogle Scholar
  23. de Kok TM et al (1999) Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas. Dig Dis Sci 44:2218–2225PubMedCrossRefGoogle Scholar
  24. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C (2000) Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914–919PubMedCrossRefGoogle Scholar
  25. Krukonis ES, Yu RR, Dirita VJ (2000) The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane-localized transcriptional activators on a single promoter. Mol Microbiol 38:67–84PubMedCrossRefGoogle Scholar
  26. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE (1995) Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 16:45–55PubMedCrossRefGoogle Scholar
  27. Merrell DS et al (2002) Host-induced epidemic spread of the cholera bacterium. Nature 417:642–645PubMedCrossRefGoogle Scholar
  28. Metcalf WW, Jiang W, Daniels LL, Kim SK, Haldimann A, Wanner BL (1996) Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria. Plasmid 35:1–13PubMedCrossRefGoogle Scholar
  29. Miller VL, Mekalanos JJ (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170:2575–2583PubMedGoogle Scholar
  30. Murakami S, Nakashima R, Yamashita E, Yamaguchi A (2002) Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587–593PubMedCrossRefGoogle Scholar
  31. Nikaido H (2001) Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 12:215–223PubMedCrossRefGoogle Scholar
  32. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656PubMedCrossRefGoogle Scholar
  33. Poole K (2002) Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol 3:77–98PubMedCrossRefGoogle Scholar
  34. Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20–51PubMedCrossRefGoogle Scholar
  35. Pratt LA, Hsing W, Gibson KE, Silhavy TJ (1996) From acids to osmZ: multiple factors influence synthesis of the OmpF and OmpC porins in Escherichia coli. Mol Microbiol 20:911–917PubMedCrossRefGoogle Scholar
  36. Prouty AM, Brodsky IE, Falkow S, Gunn JS (2004) Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium. Microbiology 150:775–783PubMedCrossRefGoogle Scholar
  37. Prouty MG, Osorio CR, Klose KE (2005) Characterization of functional domains of the Vibrio cholerae virulence regulator ToxT. Mol Microbiol 58:1143–1156PubMedCrossRefGoogle Scholar
  38. Provenzano D, Klose KE (2000) Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization. Proc Natl Acad Sci USA 97:10220–10224PubMedCrossRefGoogle Scholar
  39. Provenzano D, Schuhmacher DA, Barker JL, Klose KE (2000) The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species. Infect Immun 68:1491–1497PubMedCrossRefGoogle Scholar
  40. Reidl J, Klose KE (2002) Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev 26:125–139PubMedCrossRefGoogle Scholar
  41. Saier MH Jr, Paulsen IT (2001) Phylogeny of multidrug transporters. Semin Cell Dev Biol 12:205–213PubMedCrossRefGoogle Scholar
  42. Schuhmacher DA, Klose KE (1999) Environmental signals modulate ToxT-dependent virulence factor expression in Vibrio cholerae. J Bacteriol 181:1508–1514PubMedGoogle Scholar
  43. Simonet VC, Basle A, Klose KE, Delcour AH (2003) The Vibrio cholerae porins OmpU and OmpT have distinct channel properties. J Biol Chem 278:17539–17545PubMedCrossRefGoogle Scholar
  44. Skorupski K, Taylor RK (1997) Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli. Mol Microbiol 25:1003–1009PubMedCrossRefGoogle Scholar
  45. Snyder DS, McIntosh TJ (2000) The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. Biochemistry 39:11777–11787PubMedCrossRefGoogle Scholar
  46. Tacket CO et al (1998) Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun 66:692–695PubMedGoogle Scholar
  47. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ (1987) Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci USA 84:2833–2837PubMedCrossRefGoogle Scholar
  48. Thanassi DG, Cheng LW, Nikaido H (1997) Active efflux of bile salts by Escherichia coli. J Bacteriol 179:2512–2518PubMedGoogle Scholar
  49. Thelin KH, Taylor RK (1996) Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect Immun 64:2853–2856PubMedGoogle Scholar
  50. Tseng TT et al (1999) The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J Mol Microbiol Biotechnol 1:107–125PubMedGoogle Scholar
  51. Van Bambeke F, Glupczynski Y, Plesiat P, Pechere JC, Tulkens PM (2003) Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 51:1055–1065PubMedCrossRefGoogle Scholar
  52. Webber MA, Piddock LJ (2003) The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51:9–11PubMedCrossRefGoogle Scholar
  53. Wibbenmeyer JA, Provenzano D, Landry CF, Klose KE, Delcour AH (2002) Vibrio cholerae OmpU and OmpT porins are differentially affected by bile. Infect Immun 70:121–126PubMedCrossRefGoogle Scholar
  54. Xu Q, Dziejman M, Mekalanos JJ (2003) Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc Natl Acad Sci USA 100:1286–1291PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • James E. Bina
    • 1
    Email author
  • Daniele Provenzano
    • 2
  • Chunmei Wang
    • 1
  • Xiaowen R. Bina
    • 1
  • John J. Mekalanos
    • 3
  1. 1.Department of Molecular ScienceUniversity of Tennessee Health Science CenterMemphisUSA
  2. 2.Center for Biomedical Studies and Department of Biological SciencesUniversity of Texas—BrownsvilleBrownsvilleUSA
  3. 3.Department of Microbiology and Molecular GeneticsHarvard Medical SchoolBostonUSA

Personalised recommendations